https://www.selleckchem.com/products/tpen.html
reat analysis. This trial will evaluate the impact of universal, standardized, high-fidelity screening for ASD among children at 18 months of age, with a goal of providing evidence to support this strategy to detect ASD in toddlers in order to start treatment as young as possible and maximize outcomes. This study was approved by the Institutional Review Board at Drexel University (IRB protocol 1607004653). All findings will be provided by the principal investigator via email; data will be available through the NIMH Data Archive ( https//nd
Curtir
Comentario
Compartilhar
